Valuation: Electromed, Inc.

Market Cap 343M 301M 277M 260M 487M 32.38B 497M 3.33B 1.29B 16B 1.29B 1.26B 55.5B P/E 2026 *
34.1x
P/E 2027 * 28x
Enterprise Value 343M 301M 277M 260M 487M 32.38B 497M 3.33B 1.29B 16B 1.29B 1.26B 55.5B EV / Sales 2026 *
4.66x
EV / Sales 2027 * 4.11x
Free-Float
78.56%
Yield 2026 *
-
Yield 2027 * -
1 day+3.52%
1 week+7.19%
Current month+9.92%
1 month+8.36%
3 months+68.88%
6 months+45.47%
Current year+42.38%
1 week 37.5
Extreme 37.5001
43.05
1 month 35.61
Extreme 35.61
43.05
Current year 23.01
Extreme 23.01
43.05
1 year 17.73
Extreme 17.73
43.05
3 years 8.8
Extreme 8.8
43.05
5 years 8.75
Extreme 8.75
43.05
10 years 3.38
Extreme 3.38
43.05
Manager TitleAgeSince
Chief Executive Officer 61 30/06/2023
Director of Finance/CFO 44 13/11/2022
Compliance Officer - 31/08/2023
Director TitleAgeSince
Chairman 69 30/06/2023
Director/Board Member 76 20/11/2014
Director/Board Member 57 14/08/2019
Date Insider Type Main position Quantity % Market Cap.
06-07Fiscal year

Chief Executive Officer

29,100 0.3514%
06-03Fiscal year

Chief Financial Officer

31,003 0.3744%
05-14Fiscal year

Chairman

120,000 1.4501%
Change 5-day change 1-year change 3-year change Capi.($)
+3.52%+7.19%+88.54%+275.37% 343M
+1.44%+10.42%+25.66%+0.67% 191B
+1.25%-0.51%-24.17%+22.63% 143B
+1.75%+10.74%-1.31%-16.09% 139B
+0.07%-2.34%-58.48%-17.31% 65.74B
+1.18%+3.91%+16.07%+0.65% 52.27B
-0.52%-0.03%-27.04%-31.75% 43.55B
+0.37%+7.04%+14.13%+16.21% 38.41B
-0.66%+5.34%+6.24%+45.27% 36.76B
+1.26%+6.77%-11.59%-14.67% 29.91B
Average +0.97%+4.36%+2.81%+28.10% 73.98B
Weighted average by Cap. +1.04%+5.18%-3.35%+0.80%

Financials

2026 *2027 *
Net sales 73.6M 64.53M 59.48M 55.69M 104M 6.94B 107M 715M 277M 3.43B 276M 270M 11.9B 83.6M 73.3M 67.57M 63.26M 119M 7.89B 121M 812M 314M 3.9B 314M 307M 13.51B
Net income 10.53M 9.24M 8.51M 7.97M 14.95M 994M 15.26M 102M 39.59M 491M 39.55M 38.69M 1.7B 12.83M 11.25M 10.37M 9.71M 18.21M 1.21B 18.59M 125M 48.24M 598M 48.19M 47.14M 2.07B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
179
Date Price Change Volume
26/06/26 US$41.46 +3.52% 201,127
25/06/26 US$40.05 +2.38% 89,093
24/06/26 US$39.12 +1.53% 152,542
23/06/26 US$38.53 +0.34% 43,964
22/06/26 US$38.40 -0.72% 44,565
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
41.46USD
Average target price
40.33USD
Spread / Average Target
-2.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock